| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Circulation. 2000;102:3117.)
© 2000 American Heart Association, Inc.
Basic Science Reports |
From the Division of Cardiology and the Research Institute at Cedars-Sinai Medical Center and the UCLA School of Medicine (R.M., H.H., J.H., F.L., N.L.E.), the Division of Medical Physics at Cedars-Sinai Medical Center (J.W., A.L.), and the Department of Pathology at UCLA School of Medicine (M.C.F.), Los Angeles, Calif, and the Oak Ridge National Laboratory (F.F.K.), Oak Ridge, Tenn.
Correspondence to Neal Eigler, MD, Cedars-Sinai Medical Center, 8700 Beverly Blvd, Los Angeles, CA 90048. E-mail IB1surfdoc{at}aol.com
BackgroundRestenosis within stents may be prevented by ionizing radiation from an intravascular source.
Methods and ResultsA liquid ß- radiation (188Re) balloon was evaluated in a randomized and blinded porcine coronary model of stent restenosis. Group A pigs (n=17) received 0,16, 22, or 29 Gy at 0.5-mm depth, followed by stenting. Restenosis was quantified by angiography, ultrasound, and histomorphometry at 30 days. Group B (n=7) was stented first and then treated with 0 or 29 Gy with follow-up at 60 days. There was a measurable effect at 16 Gy, which improved with increasing doses. At 29 Gy, the histological stenotic area was reduced by 67% (22% versus 66% in controls, P<0.001). Radiation after stenting was equally effective; the stenotic area was reduced (21% versus 65%, P<0.001). At 16 Gy, the vessel just distal to the stent was significantly smaller than control vessels because of intimal thickening (P=0.003). Radiated vessels had distinctive histology consisting of neointimal fibrin and reduced smooth muscle cells and matrix (P<0.0001).
Conclusions188Re balloon brachytherapy in porcine coronary arteries results in dose-dependent and injury-independent inhibition of stent restenosis for up to 60 days. Restenosis at the borders of the irradiated zone is a potential limitation and may be related to underdosing. Brachytherapy with the 188Re balloon appears to be safe and feasible for clinical studies.
Key Words: balloon restenosis angioplasty stents
This article has been cited by other articles:
![]() |
K. Ohtani, K. Egashira, K. Nakano, G. Zhao, K. Funakoshi, Y. Ihara, S. Kimura, R. Tominaga, R. Morishita, and K. Sunagawa Stent-Based Local Delivery of Nuclear Factor-{kappa}B Decoy Attenuates In-Stent Restenosis in Hypercholesterolemic Rabbits Circulation, December 19, 2006; 114(25): 2773 - 2779. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.-L. Hang, M. Fu, B.-T. Hsieh, S. W. Leung, C.-J. Wu, H.-K. Yip, and G. Ting Intracoronary {beta}-Irradiation With Liquid Rhenium-188: Results of the Taiwan Radiation in Prevention of Post-Pure Balloon Angioplasty Restenosis Study Chest, October 1, 2003; 124(4): 1284 - 1293. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Finkelstein, D. McClean, S. Kar, K. Takizawa, K. Varghese, N. Baek, K. Park, M. C. Fishbein, R. Makkar, F. Litvack, et al. Local Drug Delivery via a Coronary Stent With Programmable Release Pharmacokinetics Circulation, February 11, 2003; 107(5): 777 - 784. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. F. Knapp Jr., R. H. Spencer, and J. Kropp Intravascular Radiation Therapy with Radioactive Liquid-Filled Balloons for Inhibition of Restenosis After Angioplasty: A New Opportunity for Nuclear Medicine? J. Nucl. Med., September 1, 2001; 42(9): 1384 - 1387. [Full Text] [PDF] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2000 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |